Series B startups in Boston, Massachusetts
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Superluminal Medicines | Boston | Series B | $65.5M | 2026-09-03 |
| RemotePass | Boston | Series B | $17.4M | 2026-05-20 |
| Beacon Biosignals | Boston | Series B | $11.0M | 2026-04-06 |
| Clasp.com | Boston | Series B | $20.0M | 2026-03-26 |
| Code Metal | Boston | Series B | $125.0M | 2026-02-19 |
| Precede Biosciences | Boston | Series B | $63.5M | 2026-01-12 |
| Maven AGI | Boston | Series B | $50.0M | 2025-06-18 |
| VerAI Discoveries | Boston | Series B | $24.0M | 2025-02-26 |
8 rows of the CSV in 5 of its 18 columns.
- The 147 series b startups in Boston, Massachusetts have raised $9.0B in total.
- 11 of them closed their most recent round in the last 12 months, $715.6M combined.
- The largest of those rounds is Soufflé Therapeutics' $135.0M Series B, dated October 2026.
- Bain Capital Ventures is an investor in 6 of them, more than any other fund.
- Software is the most common sector, with 71 companies (48%).
- 13% were founded in 2020 or later; the median founding year is 2014.
- The most common team size is 11 to 50 employees (35% of companies with a recorded size).
- 2 are unicorns, valued at $1 billion or more.
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
25 of 147| Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|
| Superluminal Medicines | Superluminal Medicines develops small-molecule therapeutics by combining AI, biology, and chemistry. | Artificial intelligence | Series B | $65.5M | 2026-09-03 | $223.5M | Insight Partners, RA Capital Management, NVentures | 11 to 50 | 2022 |
| RemotePass | RemotePass provides a platform for onboarding, managing, and paying contractors and employees. | Fintech | Series B | $17.4M | 2026-05-20 | $27.9M | F6 Ventures, 212, BECO Capital +2 | 1,001 to 5,000 | 2021 |
| Beacon Biosignals | Beacon Biosignals uses neurotechnology to measure brain activity for clinical trials and patient treatment. | Artificial intelligence | Series B | $11.0M | 2026-04-06 | $127.0M | General Catalyst, Half Court Ventures, Indicator Ventures +1 | 101 to 250 | 2019 |
| Clasp.com | Clasp.com is a fintech company helping employers attract and retain talent in hard-to-hire fields. | Education | Series B | $20.0M | 2026-03-26 | $180.8M | Slow Ventures, Pear VC, Crosslink Capital +2 | 51 to 100 | 2018 |
| Code Metal | Code Metal provides AI-enabled, verifiable code translation and optimization for edge development and modernization. | Artificial intelligence | Series B | $125.0M | 2026-02-19 | $184.4M | J2 Ventures, Shield Capital, Underdog Labs | 51 to 100 | 2023 |
| Precede Biosciences | Precede Biosciences develops blood-based tests that reveal disease-defining transcriptional biology. | Biotech | Series B | $63.5M | 2026-01-12 | $140.5M | Bristol-Myers Squibb, Lilly Asia Ventures, 5AM Ventures +2 | 11 to 50 | 2005 |
| Maven AGI | Maven AGI offers a generative AI platform that reimagines customer experience, starting with support. | Artificial intelligence | Series B | $50.0M | 2025-06-18 | $78.0M | Lux Capital, M13, E14 Fund | 51 to 100 | 2023 |
| VideaHealth | VideaHealth offers dentistAI software that automatically detects pathologies in dental imaging to help dentists avoid missed diagnoses. | Biotech | Series B | $40.0M | 2025-01-28 | $66.5M | Spark Capital, Zetta Venture Partners, Pillar VC +2 | 51 to 100 | 2018 |
| ZOE | ZOE provides personalized nutrition programs aimed at improving people's health. | Health care | Series B | $15.0M | 2024-07-29 | $117.4M | Balderton Capital, Accomplice, L Catterton +1 | 251 to 500 | 2017 |
| Cardurion Pharmaceuticals | Cardurion Pharmaceuticals develops cardiovascular therapeutics for heart failure and related diseases. | Biotech | Series B | $260.0M | 2024-07-16 | $603.1M | New Enterprise Associates, Google Ventures, Fidelity +1 | 11 to 50 | 2017 |
| Form Health | Form Health provides evidence-based obesity care through virtual consultations with physicians and dietitians. | Health care | Series B | $38.0M | 2024-06-26 | $64.3M | SignalFire, M13, NextView Ventures +1 | 101 to 250 | 2019 |
| CodaMetrix | CodaMetrix offers an AI-powered medical coding platform for healthcare revenue cycle management. | Artificial intelligence | Series B | $40.0M | 2024-03-12 | $95.0M | SignalFire, Martin Ventures, Transformation Capital +1 | 101 to 250 | 2019 |
| Legit Security | Legit Security provides a platform that identifies, ranks, and remediates security issues across workflows. | Artificial intelligence | Series B | $40.0M | 2023-09-20 | $73.5M | Bessemer Venture Partners, CRV, TCV +2 | 51 to 100 | 2021 |
| Asimov | Asimov uses artificial intelligence to build tools for designing and manufacturing therapeutics. | Artificial intelligence | Series B | $175.0M | 2023-01-05 | $205.0M | Andreessen Horowitz, DCVC, Fidelity +2 | 101 to 250 | 2017 |
| Metalenz | Metalenz designs and sells metasurface optics for sensing in consumer electronics and automotive markets. | Hardware | Series B | $30.0M | 2022-10-05 | $47.4M | Intel Capital, Global Brain Corporation, Foothill Ventures +2 | 11 to 50 | 2016 |
| JobGet | JobGet is a marketplace where employers and job seekers message, schedule and video interview each other. | Commerce | Series B | $40.0M | 2022-06-23 | $54.4M | MassChallenge, Pillar VC, Sanabil +2 | 101 to 250 | 2019 |
| Vendr Unicorn | Vendr is a SaaS buying and management platform that helps companies find, buy, and manage software. | Software | Series B | $150.0M | 2022-06-16 | $216.0M | Y Combinator, Liquid 2 Ventures, Tiger Global Management +2 | 101 to 250 | 2019 |
| Lusha Unicorn | Lusha provides a crowdsourced B2B data platform for sales and marketing professionals. | Software | Series B | $205.0M | 2021-11-10 | $245.0M | PSG Equity, ION Crossover Partners | 251 to 500 | 2016 |
| Origin | Origin is a financial planning platform that manages employee compensation, benefits, and personal finances. | Artificial intelligence | Series B | $56.0M | 2021-08-30 | $72.0M | General Catalyst, Founders Fund, Felicis +2 | 101 to 250 | 2018 |
| BondLink | BondLink builds technology products and tools to help modernize the municipal bond market. | Fintech | Series B | $18.0M | 2021-05-26 | $30.0M | Coatue, Franklin Templeton, Accomplice +1 | 11 to 50 | 2016 |
| Cobalt | Cobalt offers a PtaaS platform that combines manual security testing with transparency for security and development teams. | Cybersecurity | Series B | $29.0M | 2020-08-20 | $37.0M | Plug and Play, Alchemist Accelerator, Boost VC +2 | 251 to 500 | 2013 |
| Kinvey | Kinvey provides a backend-as-a-service that helps developers set up and run cloud backends for mobile apps. | Software | Series B | $10.9M | 2014-09-23 | $17.9M | Techstars, Atlas Venture, NTT DOCOMO Ventures +2 | 11 to 50 | 2010 |
| Covestor | Covestor builds portfolio sync technology that lets investors choose investment managers through online marketplaces. | Commerce | Series B | $13.0M | 2013-06-13 | $24.1M | Spark Capital, Union Square Ventures, Betaworks +2 | 251 to 500 | 2005 |
| Cloudant | Cloudant provides a distributed database-as-a-service that scales and manages databases for web and mobile developers. | Software | Series B | $12.0M | 2013-05-14 | $16.2M | Y Combinator, Eight Roads Ventures, F-Prime +1 | 51 to 100 | 2008 |
| NetWitness | NetWitness sells network security monitoring software to commercial and government organizations worldwide. | Cybersecurity | Series B | $5.7M | 2010-01-14 | $15.7M | Summit Partners, Alsop Louie Partners | 1,001 to 5,000 | 1997 |
Table 1. Series B startups in Boston, Massachusetts: the 25 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 147.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Code Metal | Code Metal provides AI-enabled, verifiable code translation and optimization for edge development and modernization. | Artificial intelligence | Series B | $125.0M | 2026-02-19 | $184.4M | J2 Ventures, Shield Capital, Underdog Labs | 51 to 100 | 2023 |
| 2 | Superluminal Medicines | Superluminal Medicines develops small-molecule therapeutics by combining AI, biology, and chemistry. | Artificial intelligence | Series B | $65.5M | 2026-09-03 | $223.5M | Insight Partners, RA Capital Management, NVentures | 11 to 50 | 2022 |
| 3 | Precede Biosciences | Precede Biosciences develops blood-based tests that reveal disease-defining transcriptional biology. | Biotech | Series B | $63.5M | 2026-01-12 | $140.5M | Bristol-Myers Squibb, Lilly Asia Ventures, 5AM Ventures +2 | 11 to 50 | 2005 |
| 4 | Clasp.com | Clasp.com is a fintech company helping employers attract and retain talent in hard-to-hire fields. | Education | Series B | $20.0M | 2026-03-26 | $180.8M | Slow Ventures, Pear VC, Crosslink Capital +2 | 51 to 100 | 2018 |
| 5 | RemotePass | RemotePass provides a platform for onboarding, managing, and paying contractors and employees. | Fintech | Series B | $17.4M | 2026-05-20 | $27.9M | F6 Ventures, 212, BECO Capital +2 | 1,001 to 5,000 | 2021 |
| 6 | Beacon Biosignals | Beacon Biosignals uses neurotechnology to measure brain activity for clinical trials and patient treatment. | Artificial intelligence | Series B | $11.0M | 2026-04-06 | $127.0M | General Catalyst, Half Court Ventures, Indicator Ventures +1 | 101 to 250 | 2019 |
Table 2. Series B startups in Boston, Massachusetts: the 6 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Bain Capital Ventures | Venture capital firm | San Francisco, United States | 6 | 4% | ||
| 2 | Insight Partners | Private equity firm | New York, United States | 4 | 3% | 1 | Superluminal Medicines |
| 3 | Spark Capital | Venture capital firm | San Francisco, United States | 4 | 3% | ||
| 4 | Alumni Ventures | Angel group | Manchester, United States | 4 | 3% | ||
| 5 | .406 Ventures | Venture capital firm | Boston, United States | 4 | 3% | ||
| 6 | Techstars | Startup accelerator | New York, United States | 4 | 3% | ||
| 7 | General Catalyst | Venture capital firm | San Francisco, United States | 3 | 2% | 1 | Beacon Biosignals |
| 8 | Right Side Capital Management | Micro VC fund | San Francisco, United States | 3 | 2% | ||
| 9 | Sigma Partners | Venture capital firm | Boston, United States | 3 | 2% | ||
| 10 | Glasswing Ventures | Venture capital firm | Boston, United States | 3 | 2% | ||
| 11 | Matrix | Venture capital firm | Cambridge, United States | 3 | 2% | ||
| 12 | M13 | Venture capital firm | Los Angeles, United States | 2 | 1% | ||
| 13 | Pillar VC | Venture capital firm | Boston, United States | 2 | 1% | ||
| 14 | Accomplice | Family office | Cambridge, United States | 2 | 1% | ||
| 15 | National Science Foundation | Entrepreneurship program | Alexandria, United States | 2 | 1% |
Table 3. Series B startups in Boston, Massachusetts: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Software | 71 | 48% | $3.9B |
| Health care | 61 | 41% | $4.9B |
| Biotech | 40 | 27% | $3.7B |
| Artificial intelligence | 23 | 16% | $1.7B |
| Hardware | 23 | 16% | $1.5B |
| Fintech | 15 | 10% | $632.6M |
| Cybersecurity | 13 | 9% | $601.0M |
| Commerce | 10 | 7% | $472.1M |
| Energy | 3 | 2% | $71.0M |
| Education | 2 | 1% | $210.8M |
Table 4. Series B startups in Boston, Massachusetts by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series B | 147 | 100% | $22.0M |
Table 5. Series B startups in Boston, Massachusetts by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| October 2026 | 1 | 9% | $135.0M |
| September 2026 | 1 | 9% | $65.5M |
| June 2026 | 1 | 9% | $40.0M |
| May 2026 | 1 | 9% | $17.4M |
| April 2026 | 1 | 9% | $11.0M |
| March 2026 | 1 | 9% | $20.0M |
| February 2026 | 1 | 9% | $125.0M |
| January 2026 | 3 | 27% | $242.5M |
| November 2025 | 1 | 9% | $59.2M |
Table 6. Series B startups in Boston, Massachusetts: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 10 | 7% | $656.4M |
| 2025 | 12 | 8% | $826.2M |
| 2024 | 12 | 8% | $750.3M |
| 2023 | 14 | 10% | $614.8M |
| 2022 | 15 | 10% | $534.1M |
| 2021 | 18 | 12% | $937.0M |
Table 7. Series B startups in Boston, Massachusetts by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 2 | 1% |
| 2020 to 2022 | 17 | 12% |
| 2015 to 2019 | 52 | 36% |
| 2010 to 2014 | 31 | 21% |
| Before 2010 | 44 | 30% |
Table 8. Series B startups in Boston, Massachusetts by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 16 | 11% |
| 11 to 50 | 51 | 35% |
| 51 to 100 | 36 | 25% |
| 101 to 250 | 28 | 19% |
| 251 to 500 | 7 | 5% |
| 501 to 1,000 | 2 | 1% |
| 1,001 to 5,000 | 4 | 3% |
Table 9. Series B startups in Boston, Massachusetts by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when its most recent funding round is Series B and its headquarters is in Boston, Massachusetts. On 16 November 2026 that is 147 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 25 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 147 rows: 10 have no round amount, 0 no city and 9 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many series b startups in Boston, Massachusetts are on the list?
- 147, in the file dated 16 November 2026. 11 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 147 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.